Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Liu

Showing results (491-500 of 574) with videos related to

Pageof 58
Sort By:
Lung Cancer (Amsterdam, Netherlands)|July 29, 2024
Treatment patterns and outcomes in KRAS<sup>G12C</sup>-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort studySamir H Barghout, Luna Jia Zhan, Starvroula Raptis, et al.
Genome Medicine|February 5, 2024
Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratificationXinan Wang, Ziwei Zhang, Yi Ding, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 14, 2017
The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program EfficiencySonya Cressman, Stuart J Peacock, Martin C Tammemägi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2019
Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer ConsortiumDaniel Shepshelovich, Wei Xu, Lin Lu, et al.
Nature Genetics|October 15, 2013
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagusDavid M Levine, Weronica E Ek, Rui Zhang, et al.
Research Square|August 20, 2025
Genes associated with genetic and rare lung diseases and the risk of lung cancerAlbert Rosenberger, Heike Bickeböller, David C Christiani, et al.
Lung Cancer (Amsterdam, Netherlands)|December 22, 2020
The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patientsMei Jiang, Aline F Fares, Daniel Shepshelovich, et al.
Nature Communications|September 7, 2024
Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization studyAbhinav Thakral, John Jw Lee, Tianzhichao Hou, et al.
European Journal of Medical Research|February 1, 2022
Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancerAlbert Rosenberger, Nils Muttray, Rayjean J Hung, et al.
American Journal of Epidemiology|September 19, 2012
Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer ConsortiumDarren R Brenner, Paolo Boffetta, Eric J Duell, et al.
Pageof 58

Showing results (491-500 of 574) with videos related to

Sort By:
Pageof 58
Lung Cancer (Amsterdam, Netherlands)|July 29, 2024
Treatment patterns and outcomes in KRAS<sup>G12C</sup>-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort studySamir H Barghout, Luna Jia Zhan, Starvroula Raptis, et al.
Genome Medicine|February 5, 2024
Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratificationXinan Wang, Ziwei Zhang, Yi Ding, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 14, 2017
The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program EfficiencySonya Cressman, Stuart J Peacock, Martin C Tammemägi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2019
Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer ConsortiumDaniel Shepshelovich, Wei Xu, Lin Lu, et al.
Nature Genetics|October 15, 2013
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagusDavid M Levine, Weronica E Ek, Rui Zhang, et al.
Research Square|August 20, 2025
Genes associated with genetic and rare lung diseases and the risk of lung cancerAlbert Rosenberger, Heike Bickeböller, David C Christiani, et al.
Lung Cancer (Amsterdam, Netherlands)|December 22, 2020
The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patientsMei Jiang, Aline F Fares, Daniel Shepshelovich, et al.
Nature Communications|September 7, 2024
Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization studyAbhinav Thakral, John Jw Lee, Tianzhichao Hou, et al.
European Journal of Medical Research|February 1, 2022
Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancerAlbert Rosenberger, Nils Muttray, Rayjean J Hung, et al.
American Journal of Epidemiology|September 19, 2012
Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer ConsortiumDarren R Brenner, Paolo Boffetta, Eric J Duell, et al.
Pageof 58